RightAnswer Knowledge Solutions Search Results for 21679-17-1

New Search  |  Search Results (21679-17-1)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp

All Other Data Sources:

CCRIS Documentshelp
HSDB® Data Bankhelp
LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp

ChemID External Links:

PubChemhelp
Fludarabine [INN]
PubMedhelp
Fludarabine [INN]
PubMed AIDShelp
Fludarabine [INN]
PubMed Cancerhelp
Fludarabine [INN]
PubMed Healthhelp
Fludarabine [INN]
PubMed Toxicologyhelp
Fludarabine [INN]
TOXLINEhelp
Fludarabine [INN]

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for 21679-17-1:


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. WITH THERAPEUTIC USE
    1. The most commonly reported adverse effects are myelosuppression (neutropenia, thrombocytopenia, and anemia), fever, chills, infections (pneumonia), nausea and vomiting, malaise, fatigue, anorexia and weakness. Nervous system effects such as agitation, confusion, visual disturbances, peripheral neuropathy, and coma have also been reported. Pulmonary hypersensitivity reactions (dyspnea, cough, and interstitial pulmonary infiltrate) can occur. Edema is frequently reported. Life-threatening hemolytic anemia has been reported.
  1. WITH POISONING/EXPOSURE
    1. Limited overdose data available. Overdose effects are expected to be an extension of adverse effects reported with high dose therapeutic use. Irreversible central nervous system toxicity (ie, blindness, coma, and death), as well as thrombocytopenia and neutropenia have resulted from high dose fludarabine.
© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.